Point72 Asset Management’s TriSalus Life Sciences TLSI Stock Holding History

Point72 Asset Management’s Portfolio TLSI Stock Details TLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-200,000	Closed	-$1.99M	–	1792
2022 Q3	$1.99M	Hold	200,000	–	–	0.01%	927
2022 Q2	$1.97M	Hold	200,000	–	–	0.01%	941
2022 Q1	$1.96M	Hold	200,000	–	–	0.01%	879
2021 Q4	$1.98M	Hold	200,000	–	–	0.01%	822
2021 Q3	$1.99M	Hold	200,000	–	–	0.01%	787
2021 Q2	$1.94M	Hold	200,000	–	–	0.01%	732
2021 Q1	$1.93M	Buy	+200,000	New	+$2.03M	0.01%	731

Other funds holding TLSI

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

DFCM

Dark Forest Capital Management San Juan, Puerto Rico $1.13B AUM 18.74% 1-Year Est. Return

SIA

SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Point72 Asset Management's TLSI Position: Q4 2022 in Review

Point72 Asset Management sold out of TriSalus Life Sciences (TLSI) in Q4 2022, closing a stake of 200,000 shares — an estimated $1.99M sold.

Point72 Asset Management first reported a position in TLSI in Q1 2021 and held it in 7 quarters. The position peaked at $1.99M in Q3 2022. 9 funds tracked by Wall St. Rank hold TLSI as of Q4 2022.

Point72 Asset Management reported no remaining TriSalus Life Sciences position as of Q4 2022 after selling out during the quarter.
Point72 Asset Management sold 200,000 TriSalus Life Sciences shares in Q4 2022, an estimated $1.99M.
Point72 Asset Management first reported a position in TriSalus Life Sciences in Q1 2021 and held it in 7 quarters.
Point72 Asset Management's TriSalus Life Sciences position peaked at $1.99M in Q3 2022.
9 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q4 2022.

Based on Point72 Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.